Amdocs: Amdocs Expands Relationship with T-Mobile Austria Printer-Friendly Version (NewsRx.com) -- Amdocs (NYSE:DOX), the leading provider of customer experience systems, announced it has expanded its relationship with T -Mobile Austria, a wholly owned subsidiary of T -Mobile...
Pegylated liposomal doxorubicin effective in hard-to-treat cutaneous T-cell lymphoma NEW YORK (Reuters Health) - Pegylated liposomal doxorubicin (Caelyx; Schering-Plough) is an effective therapy for advanced or refractory cutaneous T -cell lymphoma (CTCL), results of a study confirm.In a previous study, researchers...
Gene Technique That Alters CCR5-Producing Gene Increases Resistance to HIV in Mice, Study Finds Altering the gene that produces CCR5 protein on the surface of immune cells using a harmless virus was found to significantly increase resistance to HIV in mice, according to a study published Sunday in the journal Nature Biotechnology, the...
Gene technique that alters CCR5-producing gene increases resistance to HIV in mice Altering the gene that produces CCR5 protein on the surface of immune cells using a harmless virus was found to significantly increase resistance to HIV in mice, according to a study published Sunday in the journal Nature Biotechnology, the...
Political Participation Is Partially Rooted In Genetic Inheritance The decision to vote is partly genetic, according to a new study published in the American Political Science Review.The research, by James H.
Fowler and Christopher T.
Dawes, of the University of California, San Diego and Laura...
Controlling Chagas' disease in urban Peru Researchers are tracking the spread of Chagas' disease in urban areas of Peru to develop models that will allow the health ministry to target both screening in the population and house spraying campaigns against the insect that spreads the...
Crohn's disease: beyond antagonists of tumour necrosis factor Bamias G, Nyce MR, De La Rue SA, Cominelli F.New concepts in the pathophysiology of inflammatory bowel disease.
Ann Intern Med 2005; 143: 895-904.
Baumgart DC, Carding SR.
Inflammatory bowel disease: cause and immunobiology.
New drugs for Crohn's disease A range of new and developing treatments for Crohn's disease are targeting not only on the autoimmune response associated with the condition, but also aiming to reinforce the intestinal barrier.These treatments and their methods of action...
H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study Eichwald EJ, Silmser CR.Skin.
Transplant Bull 1955; 2: 148-149.
Goulmy E, Termijtelen A, Bradley BA, van Rood JJ.
Y-antigen killing by T cells of women is restricted by HLA.
Nature 1977; 266: 544-545.
MEDLINE | CrossRef 3....
Private Hospitals & Clinics (UK) - Portfolio Analysis Available Now for your Specialised Research DUBLIN, Ireland-- (BUSINESS WIRE) -- Research and Markets (http://www.researchandmarkets.com/research/d1b0ee/private_hospitals) has announced the addition of the 'Private Hospitals & Clinics (UK) - Portfolio Analysis' report to their...
Pegylated liposomal doxorubicin effective in hard-to-treat cutaneous T-cell lymphoma NEW YORK (Reuters Health) - Pegylated liposomal doxorubicin (Caelyx; Schering-Plough) is an effective therapy for advanced or refractory cutaneous T -cell lymphoma (CTCL), results of a study confirm.In a previous study, researchers...
Salix begins enrolment in rifaximin phase 3 study for IBS patients Salix Pharmaceuticals, Ltd.announced that the company has initiated patient enrolment in TARGET 1 and TARGET 2, its phase 3, randomized, double-blind, placebo-controlled, multicenter studies to assess the efficacy and safety of rifaximin...
Coffee and multiple sclerosis The study investigated the effect of a particular protein on a model of MS, not the effect of coffee directly Drinking several cups of coffee a day could halt the development of multiple sclerosis, reads a story in The Daily Telegraph...
Genetic 'Snip' Could Help Make CD4 HIV-Proof, Experiment Suggests Some people have a mutation that makes them amazingly resistant to HIV -- and now, scientists may have found a way to give that immunity to anyone.Viruses enter cells and take them over, but to get inside, they need a handhold.
HIV...
Treatment for HIV may become a reality soon Apotential therapy for HIV could soon become a reality, if scientists are to be believed.In their ground-breaking study, a team at Pennsylvania University made laboratory rodents HIV resistant by sabotaging a gene in blood cells that the...
Breast Cancer Vaccines Look Promising Various cancer vaccines that have been studied for decades use cancer cells, parts of cells or substances called antigens to trigger an immune response against cancer cells already in the body.istockphoto.com THURSDAY, June 26 (HealthDay...
Transgenic wheat has increased polyamines Crop productivity relies heavily on abundant supplies of water for irrigation.Although drought and salt tolerance genes are present in wheat, breeding for stress tolerance is time- and labour-intensive and complicated by the multigenic...
FDA files application to convert ONTAK(R) (Denileukin Diftitox) to full approval for use in Cutaneous T-Cell L WOODCLIFF LAKE, N.J.- Eisai Corporation of North America announced today that the U.S.
Food and Drug Administration (FDA) has accepted for priority review a supplemental biologics license application (sBLA) for ONTAK(R).
The sBLA...
Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference Rosetta Genomics Ltd (Nasdaq: ROSG), a leading developer of microRNA-based diagnostics and therapeutics, announced today it will present Collins Stewart Fourth Annual Growth Conference on Wednesday, July 9, at 8:30 am EST at the Mandarin...
Study Might Lead To New AIDS Treatment scientists say they've used tiny proteins called zinc fingers to modify T -cell receptor genes in a study that may lead to a new type of AIDS treatment.Researchers at the University of Pennsylvania School of Medicine and colleagues...
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas FREE Peripheral T -cell lymphomas (PTCLs) are fatal in the majority of patients and novel treatments, such as protein tyrosine kinase (PTK) inhibition, are needed.The recent finding of SYK/ITK translocations in rare PTCLs led us to...
Yeast-based vaccine provides rationale for human cancer studies Scientists have found that vaccination with a heat-killed, nontoxic yeast that is genetically engineered to manufacture a common tumor protein can induce specific and repeated anti-tumor immune responses in mice.Vaccination extends...
HAART May Increase Asthma Risk in Children With HIV -- Children whose immune systems rebound after treatment with highly active antiretroviral therapy (HAART) for HIV infection face an increased risk of developing asthma, according to a study published in the Journal of Allergy and Clinical...
HAART May Increase Asthma Risk in Children With HIV -- Children whose immune systems rebound after treatment with highly active antiretroviral therapy (HAART) for HIV infection face an increased risk of developing asthma, according to a study published in the Journal of Allergy and Clinical...
Miller family to run in Chicago Marathon for charity Holland, MI - Dave Miller, the freshman boys basketball coach at West Ottawa, and his wife, Erin, are involved in one of their biggest projects of their young lives.Well be running the Chicago Marathon on Oct.
12 in honor of Kate...
